SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-019800
Filing Date
2024-07-18
Accepted
2024-07-18 20:06:39
Documents
1
Period of Report
2024-07-18

Document Format Files

Seq Description Document Type Size
1 form3-07192024_120734.html 3  
1 form3-07192024_120734.xml 3 3407
  Complete submission text file 0001415889-24-019800.txt   5123
Mailing Address WELLINGTON ALTERNATIVE INVESTMENTS LLC 280 CONGRESS STREET BOSTON MA 02210
Business Address WELLINGTON ALTERNATIVE INVESTMENTS LLC 280 CONGRESS STREET BOSTON MA 02210 (617) 951-5372
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (Reporting) CIK: 0001787092 (see all company filings)

State of Incorp.: E9
Type: 3 | Act: 34 | File No.: 001-42179 | Film No.: 241125807

Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Issuer) CIK: 0001817241 (see all company filings)

IRS No.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)